Systemic lupus erythematosus (SLE): Nursing

Last updated: April 13, 2022

Systemic lupus erythematosus (SLE): Nursing

Watch later

Watch later

Infection prevention and control - Precautions and personal protective equipment (PPE): Nursing skills
Urinary tract infections (UTIs): Nursing process (ADPIE)
Modes of infectious disease transmission
Epstein-Barr virus (Infectious mononucleosis)
Pneumonia
Wound healing
Palliative and hospice care: Nursing
Postoperative care: Nursing
Biology of cancer: Nursing
Biliary atresia: Nursing
Cholecystitis: Nursing
Cholelithiasis: Nursing
Colorectal cancer: Nursing
Diarrhea: Nursing
Diverticular disease: Nursing
Esophageal cancer: Nursing
Gastric cancer: Nursing
Hepatitis: Nursing
Inflammatory bowel disease - Crohn disease and ulcerative colitis: Nursing
Intestinal obstruction: Nursing
Irritable bowel syndrome (IBS): Nursing
Jaundice: Nursing
Laryngeal cancer: Nursing
Liver cancer: Nursing
Pancreatic cancer: Nursing
Esophageal atresia and tracheoesophageal fistula: Nursing
Geriatric considerations - Gastrointestinal: Nursing
Hirschsprung disease: Nursing
Hyperemesis gravidarum: Nursing
Necrotizing enterocolitis: Nursing
Omphalocele and gastroschisis: Nursing
Appendicitis: Nursing process (ADPIE)
Celiac disease: Nursing process (ADPIE)
Cirrhosis: Nursing process (ADPIE)
Gastroesophageal reflux disease (GERD): Nursing process (ADPIE)
Hiatal hernia: Nursing process (ADPIE)
Pancreatitis: Nursing process (ADPIE)
Peptic ulcer disease (PUD): Nursing process (ADPIE)
Antacids: Nursing pharmacology
Antidiarrheals: Nursing pharmacology
Antiemetics: Nursing pharmacology
Antispasmodics (GI): Nursing pharmacology
Gallstone-dissolving agents: Nursing pharmacology
Gastric mucosal protective agents: Nursing pharmacology
Histamine H2 antagonists: Nursing pharmacology
Laxatives: Nursing pharmacology
Medications for hepatic encephalopathy: Nursing pharmacology
Pancreatic enzyme replacements: Nursing pharmacology
Proton pump inhibitors (PPIs): Nursing pharmacology
Treatment for Helicobacter pylori: Nursing pharmacology
Weight loss medications: Nursing pharmacology
Bladder tumors: Nursing
Chronic kidney disease (CKD): Nursing
Dialysis care: Nursing
Epididymitis: Nursing
Glomerulonephritis: Nursing
Nephrotic syndrome: Nursing
Polycystic kidney disease (PKD): Nursing
Prostate cancer: Nursing
Pyelonephritis: Nursing
Renal and urinary calculi: Nursing
Renal cancer: Nursing
Testicular cancer: Nursing
Urinary retention: Nursing
Bladder exstrophy: Nursing
Circumcision: Nursing
Cryptorchidism: Nursing
Enuresis: Nursing
Geriatric considerations - Urinary: Nursing
Hypospadias and epispadias: Nursing
Acute kidney injury (AKI): Nursing process (ADPIE)
Benign prostatic hyperplasia (BPH): Nursing process (ADPIE)
Urinary incontinence - Stress: Nursing process (ADPIE)
Antispasmodics (GU): Nursing pharmacology
Cholinergic therapy (GU): Nursing pharmacology
Diuretics - Osmotic and carbonic anhydrase inhibitors: Nursing pharmacology
Diuretics - Thiazide, thiazide-like, loop, and potassium-sparing diuretics: Nursing pharmacology
Anemia - Aplastic: Nursing
Anemia - Iron-deficiency: Nursing
Anemia - Macrocytic: Nursing
Arterial blood gas (ABG) - Overview: Nursing
Arterial blood gas (ABG) - Metabolic acidosis: Nursing
Arterial blood gas (ABG) - Metabolic alkalosis: Nursing
Arterial blood gas (ABG) - Respiratory acidosis: Nursing
Arterial blood gas (ABG) - Respiratory alkalosis: Nursing
Blood cultures: Nursing
Cardiac biomarkers - Creatine kinase (CK): Nursing
Cardiac biomarkers - Troponin: Nursing
Coagulation studies - Partial thromboplastin time (PTT): Nursing
Complete blood count (CBC) - Hemoglobin and hematocrit: Nursing
Complete blood count (CBC) - Platelets: Nursing
Complete blood count (CBC) - Red blood cells (RBC): Nursing
Complete blood count (CBC) - White blood cells (WBC) and differential: Nursing
Complete metabolic panel (CMP) - Blood urea nitrogen (BUN) and creatinine (Cr): Nursing
Complete metabolic panel (CMP) - Chloride: Nursing
Complete metabolic panel (CMP) - Estimated glomerular filtration rate (eGFR): Nursing
Complete metabolic panel (CMP) - Glucose: Nursing
Complete metabolic panel (CMP) - Liver function tests (LFT): Nursing
Complete metabolic panel (CMP) - Potassium: Nursing
Complete metabolic panel (CMP) - Sodium: Nursing
Complete metabolic panel (CMP) - Total protein: Nursing
Disseminated intravascular coagulation (DIC): Nursing
Multiple myeloma: Nursing
Neutropenia: Nursing
Polycythemia: Nursing
Thalassemia: Nursing
Thrombocytopenia: Nursing
Leukemia: Nursing process (ADPIE)
Anticoagulants - Direct thrombin and factor Xa inhibitors: Nursing pharmacology
Anticoagulants - Heparin: Nursing pharmacology
Anticoagulants - Warfarin: Nursing pharmacology
Antihyperlipidemics - Bile acid sequestrants and cholesterol absorption inhibitors: Nursing pharmacology
Antihyperlipidemics - Fibrates: Nursing pharmacology
Antihyperlipidemics - Miscellaneous: Nursing pharmacology
Antihyperlipidemics - Statins: Nursing pharmacology
Antiplatelet agents: Nursing pharmacology
Blood products: Nursing pharmacology
Hematopoietic growth factors: Nursing pharmacology
Hemostatics: Nursing pharmacology
Iron preparations: Nursing pharmacology
Thrombolytics: Nursing pharmacology
Autoimmunity: Nursing
Human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS): Nursing
Hypersensitivity reactions - Type I: Nursing
Hypersensitivity reactions - Type II: Nursing
Hypersensitivity reactions - Type III: Nursing
Hypersensitivity reactions - Type IV: Nursing
Immune response - Adaptive: Nursing
Immune response - Innate: Nursing
Immunodeficiency disorders - Primary: Nursing
Immunodeficiency disorders - Secondary: Nursing
Inflammatory process: Nursing
Scleroderma: Nursing
Shock - Anaphylactic: Nursing
Sjögren syndrome: Nursing
Systemic lupus erythematosus (SLE): Nursing
Toxic shock syndrome (TSS): Nursing
Erythema infectiosum (Fifth disease): Nursing
Fever: Nursing
Infectious mononucleosis: Nursing
Mumps (Parotitis): Nursing
Neonatal sepsis: Nursing
Pertussis: Nursing
Poliomyelitis: Nursing
Postpartum infections: Nursing
Roseola (Exanthem subitum): Nursing
Rubella (German measles): Nursing
Rubeola (Measles): Nursing
Smallpox: Nursing
Zika virus: Nursing
Anaphylaxis: Nursing process (ADPIE)
Lyme disease: Nursing process (ADPIE)
Rheumatoid arthritis (RA): Nursing process (ADPIE)
Antirejection immunosuppressants: Nursing pharmacology
Biologic agents: Nursing pharmacology
Disease-modifying therapy for multiple sclerosis: Nursing pharmacology
Immunoglobulins: Nursing pharmacology
Immunomodulators: Nursing pharmacology
Immunosuppressants for autoimmune diseases: Nursing pharmacology
Non-biologic disease-modifying antirheumatic drug (DMARD) therapy: Nursing pharmacology
Vaccines: Nursing pharmacology
Acne: Nursing
Animal and snake bites: Nursing
Burn injury: Nursing
Cutaneous fungal infections: Nursing
Erysipelas and cellulitis: Nursing
Folliculitis, carbuncles, and furuncles: Nursing
Herpes simplex virus (HSV): Nursing
Herpes zoster: Nursing
Impetigo: Nursing
Insect stings and bites: Nursing
Pediculosis and scabies: Nursing
Psoriasis: Nursing
Rocky Mountain spotted fever (RMSF): Nursing
Skin cancer - Basal cell carcinoma, squamous cell carcinoma, and melanoma: Nursing
Urticaria: Nursing
Geriatric considerations - Integumentary: Nursing
Atopic dermatitis: Nursing process (ADPIE)
Frostbite: Nursing process (ADPIE)
Methicillin-resistant Staphylococcus aureus (MRSA): Nursing process (ADPIE)
Pressure injury: Nursing process (ADPIE)
Antibiotics - Topical: Nursing pharmacology
Antifungals - Topical: Nursing pharmacology
Corticosteroids - Topical: Nursing pharmacology
Debridement agents: Nursing pharmacology
Keratolytics: Nursing pharmacology
Medications for acne vulgaris: Nursing pharmacology
Osteoarthritis: Nursing
Osteomyelitis: Nursing
Osteoporosis: Nursing
Hip fractures: Nursing
Developmental dysplasia of the hip: Nursing
Acute compartment syndrome: Nursing process (ADPIE)
Fractures: Nursing process (ADPIE)
Gout: Nursing process (ADPIE)
Musculoskeletal injuries: Nursing process (ADPIE)
Buerger disease: Nursing
Raynaud phenomenon: Nursing
Peripheral arterial disease (PAD): Nursing process (ADPIE)
Peripheral venous disease (PVD): Nursing process (ADPIE)
Atelectasis: Nursing
Geriatric considerations - Respiratory: Nursing
Venous thromboembolism (VTE): Nursing process (ADPIE)
Asthma: Nursing process (ADPIE)
Bacterial pneumonia: Nursing process (ADPIE)
Bronchiolitis and respiratory syncytial virus (RSV): Nursing process (ADPIE)
Carbon monoxide poisoning: Nursing process (ADPIE)
Chronic obstructive pulmonary disease (COPD): Nursing process (ADPIE)
Epiglottitis: Nursing process (ADPIE)
Foreign body aspiration and upper airway obstruction: Nursing process (ADPIE)
Laryngotracheobronchitis (LTB) and croup: Nursing process (ADPIE)
Smoke inhalation injury: Nursing process (ADPIE)
Papulosquamous and inflammatory skin disorders: Pathology review

Notes

SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)

KEY POINTS
NOTES
DEFINITION
  • Chronic autoimmune disease that affects multiple systems, mainly the skin, joints, and serous membranes

PHYSIOLOGY
  • Immune system
    • Protects the body from harmful agents
    • Foreign particle enters body
    • Engulfed by macrophages
    • Presented to T lymphocytes

CAUSES AND RISK FACTORS
  • Cause
    • Unknown
  • Risk factors
    • Multifactorial
    • Genetic susceptibility
    • Altered immune system function
    • Exposure to certain triggers
    • Assigned female at birth
    • Family history of lupus
    • Black, Hispanic, or Asian race

PATHOPHYSIOLOGY
  • Immune system forms auto-antibodies (anti-nuclear antibodies [ANA]) that target nucleic acids, such as DNA or RNA
  • ANA bind to nucleic acids and immune  complexes are formed
  • Precipitate in the walls of blood vessels supplying the brain, heart, skin, kidneys, and joints
  • Triggers type III hypersensitivity reaction
  • Chronic inflammation of the affected blood vessels
  • Complications
    • Skin damage
    • Alopecia
    • Increased risk of  coronary artery disease
    • End-stage renal disease
    • Visual changes
    • Anxiety
    • Depression
    • Gastrointestinal obstruction and inflammatory bowel syndrome
    • Pregnancy loss, preeclampsia, and eclampsia
    • Osteoporosis
    • Increased infection risk

SIGNS AND SYMPTOMS
  • Fever
  • Weight loss
  • Malar rash 
  • Discoid rash
  • Photosensitivity
  • Ulcers in mucous membranes
  • Serositis
  • Inflammation of the myocardium
  • Pain in multiple joints and myalgia
  • Glomerulonephritis, proteinuria, hematuria
  • Seizures, psychosis, personality changes, peripheral neuropathy
  • Dysphagia, nausea and vomiting, abdominal pain, diarrhea
  • Menstrual abnormalities
  • Hematologic disorders

DIAGNOSIS
  • History
  • Physical assessment
  • Laboratory tests
  • ECG
  • Urinalysis
  • X-ray

TREATMENT
  • Depends on severity of symptoms and organ systems affected
  • NSAIDs
  • Steroid-sparing medications
  • Antimalarials
  • Immunosuppressants
  • Anticoagulants

MANAGEMENT OF CARE
  • Goals of care
    • Control symptoms
    • Monitor for organ damage
    • Provide psychosocial support
  • Assess vital signs and neurological status
    • Report to HCP
      • Fever
      • Headache
      • Vision changes
      • Severe joint pain and swelling
  • Administer prescribed medications
  • Place in a comfortable position
  • Non-pharmacological pain management
  • Cluster activities
  • Monitor for organ damage
  • Insert indwelling urinary catheter
  • Monitor intake and output
    • Report to HCP
      • Elevated BP
      • Edema
      • Oliguria
      • Hematuria
      • Proteinuria
      • Cellular casts
      • Elevated BUN and creatinine

PATIENT AND FAMILY TEACHING
  • Explain condition, plan of care, and how to safely administer medications
  • Keep all follow-up appointments
  • Strategies to manage disease and improve quality of life
  • Rest
  • Stress management
  • Sleep
  • Avoid household chemicals and UV light
  • Avoid those who are sick
  • Moderate exercise
  • Dietary modifications
  • Smoking cessation
  • Report to HCP
    • Chest pain or pressure
    • Sudden weakness or light-headedness
    • Shortness of breath
    • Decreased urination
    • Increased fatigue
    • Loss of appetite
    • Hair loss
    • Skin rashes
    • New sores in mouth or nose

Transcript

Watch video only

Systemic lupus erythematosus, or simply SLE or lupus, is a chronic autoimmune disease that affects multiple systems, mainly the skin, joints, and serous membranes.

SLE is progressive, meaning that it gets worse over time with alternating periods of remission and exacerbation. A less common type of lupus particularly affects the skin, called cutaneous lupus erythematosus, or CLE for short. Clients with this condition eventually develop a full-blown SLE over time.

Now, let’s quickly recap the physiology of the immune system, which protects the body from harmful agents. This can be done with the aid of immune cells, including macrophages and lymphocytes.

So, let’s imagine that a foreign particle enters the body, it will be faced by macrophages, which swallow this harmful agent and break it down, leaving a small particle called an antigen. The macrophage then presents this antigen on its surface for another type of immune cells to recognize, called T lymphocytes. Types of T lymphocytes include cytotoxic T lymphocytes, which fight against intracellular pathogens and cancer cells by initiating cell death; as well as T helper cells, which activate another type of lymphocytes, called B lymphocytes.

Once activated, B lymphocytes can differentiate into plasma cells or memory cells. Plasma cells produce antibodies. These bind to antigens found on the surface of the pathogen, producing immune complexes.

So, an antibody tags the pathogen for other immune cells to recognize. In contrast, memory cells monitor the body for the same antigen, and when the pathogen visits the body again, these cells convert to plasma cells, and start producing antibodies to fight this pathogen even faster than the first exposure.

During development, the immune cells learn how to skip the antigens found on the surface of body cells and not react to them, called self-tolerance. This is the main function of another type of T lymphocytes, called regulatory T cells, which suppress the immune system to maintain self-tolerance.

Now, the exact cause of systemic lupus erythematosus is unknown, but it’s thought to be multifactorial, involving genetic susceptibility, altered immune system function, and exposure to certain triggers such as cigarette smoke and ultraviolet light.

Lupus is also more common in individuals assigned female at birth, especially during childbearing years; those with a family history of Lupus; and Black, Hispanic, or Asian individuals.

Alright, now the pathology of systemic lupus erythematosus starts with a genetically susceptible client, meaning that they have less functional regulatory T cells. Add a hormonal or an environmental trigger to that, and self-tolerance is lost. This causes the immune system to form auto-antibodies that target nucleic acids, such as DNA or RNA.

Therefore, these auto-antibodies are called anti-nuclear antibodies, or ANA for short. Now, when these ANAs bind to nucleic acids, immune complexes are formed, and these immune complexes eventually precipitate in the walls of blood vessels supplying the brain, heart, skin, kidneys, and joints. This triggers an abnormal immune response, called type III hypersensitivity reaction, which leads to chronic inflammation of the affected blood vessels and reduced perfusion of the affected organs.

Complications of systemic lupus erythematosus typically arise from the organ damage caused by the disease, or as a side effect of the medications used to treat the disease. These complications include skin damage, alopecia, and increased risk of coronary artery disease, in addition to end-stage renal disease.

Complications can also arise in the nervous system, including visual changes, anxiety, and depression. Complications of the gastrointestinal system include intestinal obstruction and inflammatory bowel syndrome. Complications of the reproductive system include pregnancy loss, preeclampsia, and eclampsia. Finally, clients with lupus that receive long-term steroids can develop complications, such as osteoporosis and increased risk for infections.

In terms of clinical manifestations, there are general ones, like fever and weight loss, as well as specific manifestations depending on the organ system being affected. The skin is often affected, so clients with lupus classically present with a malar rash, or "butterfly rash," over the cheeks that spares the nasolabial folds. Additional skin manifestations include a discoid rash, which is a plaque-like chronic rash in sun-exposed areas, and a general photosensitivity of the skin.

Another type of tissue that can be damaged is the mucosa of various organs, so ulcers in the mucus membrane of the mouth or the nose might be present.

Lupus can also affect the serous, or outer membrane of an organ, so clients can get serositis, which could manifest as pleuritis, or inflammation of the lining around the lungs and chest cavity; as peritonitis, which is inflammation of the lining of the abdomen, or as pericarditis, which is inflammation of the lining of the heart.

In addition to pericarditis, lupus can also cause inflammation of the myocardium, leading to myocarditis, or the endocardium, leading to Libman-Sacks endocarditis, where clumps of fibrin and immune cells form vegetations on the mitral or aortic valve. The musculoskeletal system is also frequently involved, so clients can experience pain in multiple joints, and myalgia.

Next is the urinary system, where lupus can lead to glomerulonephritis, proteinuria, and hematuria. For neurological manifestations, these include seizures, psychosis, personality changes, and peripheral neuropathy.

Gastrointestinal manifestations, such as dysphagia, nausea and vomiting, abdominal pain, and diarrhea, are also common. Some clients may also experience reproductive manifestations like menstrual abnormalities. Finally, components of the blood can be affected , causing various hematologic disorders, anemia, thrombocytopenia, and leukopenia.

The diagnosis of systemic lupus erythematosus starts with the client’s history and physical examination, followed by diagnostic tests. The gold standard test for the diagnosis of lupus is the ANA test, which measures the amount of antinuclear antibodies in the blood. Now a large proportion of clients with lupus have these, meaning this test is very sensitive, but this test isn’t very specific, since these are seen in other autoimmune diseases.

Other autoantibodies can also be detected, including anti-dsDNA, anti-Smith, which are actually relatively specific for lupus, and antiphospholipid antibodies.

Additionally, clients with lupus that has developed as a reaction to certain medications typically have elevated auto-antibodies against histones, which are small proteins around which the DNA loops.

Additional diagnostic tests are sometimes also performed, including a complete blood count, serum complement levels, electrocardiography, urinalysis, as well as chest x-ray, and x-rays of the affected joints.